Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Peter Hammes

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Deutsches Arzteblatt International|April 4, 2015
Further specification requiredHans-Peter Hammes
Therapeutic Advances in Endocrinology and Metabolism|April 30, 2013
Optimal treatment of diabetic retinopathyHans-Peter Hammes
Diabetologia|September 25, 2017
Diabetic retinopathy: hyperglycaemia, oxidative stress and beyondHans-Peter Hammes
Journal of Diabetes and Its Complications|March 8, 2003
Pathophysiological mechanisms of diabetic angiopathyHans Peter Hammes
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2012
Retinal digest preparation: a method to study diabetic retinopathyNadine Dietrich, Hans-Peter Hammes
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|May 23, 2002
[Epidemiology, pathogenesis and therapy of diabetic retinopathy and maculopathy]Claudia Jochmann, Hans-Peter Hammes
Diabetologia|August 10, 2004
"Prediction and early detection of diabetic complications: common pathways and unique needs". Keble College, Oxford Austust 1-4, 2003Mark Cooper, Hans-Peter Hammes, Antony Horton
Cytotherapy|April 6, 2020
Adipose-derived mesenchymal stromal cells reverse high glucose-induced reduction of angiogenesis in human retinal microvascular endothelial cellsAgnese Fiori, Hans-Peter Hammes, Karen Bieback
NAR Genomics and Bioinformatics|January 6, 2022
miRetrieve-an R package and web application for miRNA text miningJulian Friedrich, Hans-Peter Hammes, Guido Krenning
Klinische Monatsblatter Fur Augenheilkunde|September 16, 2024
Glucagon-like Peptide 1 Receptor Agonist: Balancing Alarm and CautionFocke Ziemssen, Hans-Peter Hammes, Horst Helbig
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Deutsches Arzteblatt International|April 4, 2015
Further specification requiredHans-Peter Hammes
Therapeutic Advances in Endocrinology and Metabolism|April 30, 2013
Optimal treatment of diabetic retinopathyHans-Peter Hammes
Diabetologia|September 25, 2017
Diabetic retinopathy: hyperglycaemia, oxidative stress and beyondHans-Peter Hammes
Journal of Diabetes and Its Complications|March 8, 2003
Pathophysiological mechanisms of diabetic angiopathyHans Peter Hammes
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2012
Retinal digest preparation: a method to study diabetic retinopathyNadine Dietrich, Hans-Peter Hammes
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|May 23, 2002
[Epidemiology, pathogenesis and therapy of diabetic retinopathy and maculopathy]Claudia Jochmann, Hans-Peter Hammes
Diabetologia|August 10, 2004
"Prediction and early detection of diabetic complications: common pathways and unique needs". Keble College, Oxford Austust 1-4, 2003Mark Cooper, Hans-Peter Hammes, Antony Horton
Cytotherapy|April 6, 2020
Adipose-derived mesenchymal stromal cells reverse high glucose-induced reduction of angiogenesis in human retinal microvascular endothelial cellsAgnese Fiori, Hans-Peter Hammes, Karen Bieback
NAR Genomics and Bioinformatics|January 6, 2022
miRetrieve-an R package and web application for miRNA text miningJulian Friedrich, Hans-Peter Hammes, Guido Krenning
Klinische Monatsblatter Fur Augenheilkunde|September 16, 2024
Glucagon-like Peptide 1 Receptor Agonist: Balancing Alarm and CautionFocke Ziemssen, Hans-Peter Hammes, Horst Helbig
Pageof 17